Rosuvastatin Calcium Tablet
Product Images NDC 50090-7967
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7967). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)
Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)
The provided text contains a comparison between Rosuvastatin 20 mg and Placebo 20 mg in terms of various cardiovascular events. It includes data on the number of events, hazard ratios, and p-values. The primary endpoint, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, and arterial revascularization are among the events analyzed. The results show a significant reduction in the primary endpoint and various cardiovascular events with Rosuvastatin compared to Placebo, as evidenced by the hazard ratios and p-values provided. The data provides valuable insights into the effectiveness of Rosuvastatin in reducing cardiovascular risk factors.*
Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)
This text mentions different statin medications such as CRESTOR, Atorvastatin, Simvastatin, and Pravastatin, along with their corresponding doses in milligrams. It might be part of a comparison or evaluation chart showing the percent change in LDL-C levels associated with these medications at different doses.*
Structural_formula (Rosuvastatin Tablets Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.